Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 1, 2005, Pages 121-124

  Kohli, Rohit ^a   Harris, David C ^a   Whitington, Peter F ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; GENE DELETION; HUMAN; MUSCULAR DYSTROPHY; PRIORITY JOURNAL;

ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC; ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL; ASPARTATE AMINOTRANSFERASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUSCULAR DYSTROPHIES;

EID: 22044441965     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNO.0000161657.98895.97     Document Type: Article

References (22)

1. Pratt DS, Kaplan MM. Evaluation of the liver: Laboratory tests. In: Schiff ER, Sorrell, MF, Maddrey, WC, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott Williams & Wilkins; 2003: 235-40.
2. Wroblewski F, Ladue JS. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med 1956;91: 569-71.
3. Tsung SH. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin Chem 1976;22:173-5.
4. Wroblewski F. The clinical significance of transaminase activities of serum. Am J Med 1959;27:911-23.
5. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-22.
6. Shaw RF, Pearson CM, Chowdhury SR, et al. Serum enzymes in sex-linked (Duchenne) muscular dystrophy. Arch Neurol 1967;16: 115-22.
7. Zamora S, Adams C, Butzner JD, et al. Elevated aminotransferase activity as an indication of muscular dystrophy: Case reports and review of the literature. Can J Gastroenterol 1996;10:389-93.
8. Korones DN, Brown MR, Palis J. "Liver function testś are not always tests of liver function. Am J Hematol 2001;66:46-8.
9. Lin YC, Lee WT, Huang SF, et al. Persistent hypertransaminasemia as the presenting findings of muscular dystrophy in childhood. Acta Paediatr Taiwan 1999;40:424-9.
10. Morse RP, Rosman NP. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr 1993;122:254-6.
11. Rutledge J, Andersen J, Fink CW, et al. Persistent hypertransaminasemia as the presenting finding of childhood muscle disease. Clin Pediatr (Phila) 1985;24:500-3.
12. Schwarz KB, Burris GC, deMello DE, et al. Prolonged elevation of transaminase concentration in children with unsuspected myopathy. Am J Dis Child 1984;138:1121-4.
13. Tim RW, Gaskell P, Stajich J. A "liver test" is not a liver test. Measuring serum creatine kinase can identify muscular dystrophy and avoid liver biopsy. N C Med J 1998;59:238-41.
14. Treem WR. Persistent elevation of transaminases as the presenting finding in an adolescent with an unsuspected muscle glycogenosis. Clin Pediatr (Phila) 1987;26:605-7.
15. Sibley J, Lehninger AL. Determination of aldolase in animal tissues. J Biol Chem 1949;177:859-72.
16. Pearson CM. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med 1957;256:1069-75.
17. Munsat TL, Baloh R, Pearson CM, et al. Serum enzyme alterations in neuromuscular disorders. JAMA 1973;226:1536-43.
18. Dunn M, Martins J, Reissmann KR. The disappearance rate of glutamic oxalacetic transaminase from the circulation and its distribution in the body's fluid compartments and secretions. J Lab Clin Med 1958;51:259-65.
19. Salinas M, Wallace R, Grisolia S. Comparative studies in vivo and in vitro of rat liver enzymes. Eur J Biochem 1974;44:375-81.
20. Kim YS. The half-life of alanine aminotransferase and of total soluble protein in livers of normal and glucocorticoid-treated rats. Mol Pharmacol 1969;5:105-8.
21. Ussery XT, Henar EL, Black DD, et al. Acute liver injury after protracted seizures in children. J Pediatr Gastroenterol Nutr 1989; 9:421-5.
22. Jackson MJ, Round JM, Newham DJ, et al. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy. Muscle Nerve 1987;10:15-21.